Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 1
1985 6
1986 3
1987 2
1988 1
1989 1
1990 5
1991 4
1992 3
1993 3
1994 4
1995 1
1996 3
1997 5
1998 4
1999 6
2000 11
2001 7
2002 19
2003 15
2004 16
2005 18
2006 12
2007 24
2008 23
2009 27
2010 25
2011 22
2012 22
2013 21
2014 22
2015 15
2016 24
2017 23
2018 22
2019 13
2020 15
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

437 results
Results by year
Filters applied: . Clear all
Page 1
Non-small-cell lung cancer.
Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, Petrella F, Spaggiari L, Rosell R. Gridelli C, et al. Nat Rev Dis Primers. 2015 May 21;1:15009. doi: 10.1038/nrdp.2015.9. Nat Rev Dis Primers. 2015. PMID: 27188576 Review.
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
Camidge DR, Kim HR, Ahn MJ, Yang JC, Han JY, Lee JS, Hochmair MJ, Li JY, Chang GC, Lee KH, Gridelli C, Delmonte A, Garcia Campelo R, Kim DW, Bearz A, Griesinger F, Morabito A, Felip E, Califano R, Ghosh S, Spira A, Gettinger SN, Tiseo M, Gupta N, Haney J, Kerstein D, Popat S. Camidge DR, et al. Among authors: gridelli c. N Engl J Med. 2018 Nov 22;379(21):2027-2039. doi: 10.1056/NEJMoa1810171. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280657 Free article. Clinical Trial.
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Früh M, Qian W, Tamura T, Samantas E, Shibata T, Perrone F, Gallo C, Gridelli C, Martelli O, Lee SM. Rossi A, et al. Among authors: gridelli c. J Clin Oncol. 2012 May 10;30(14):1692-8. doi: 10.1200/JCO.2011.40.4905. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473169 Review.
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
Ottaviano M, Curvietto M, Rescigno P, Tortora M, Palmieri G, Giannarelli D, Aieta M, Assalone P, Attademo L, Avallone A, Bloise F, Bosso D, Borzillo V, Buono G, Calderoni G, Caputo F, Cartenì G, Cavallero D, Cavo A, Ciardiello F, Conca R, Conteduca V, De Falco S, De Felice M, De Laurentiis M, De Placido P, De Placido S, De Santo I, De Stefano A, Della Corte CM, Di Franco R, Di Lauro V, Fabbrocini A, Federico P, Festino L, Giordano P, Giuliano M, Gridelli C, Grimaldi AM, Lia M, Marretta AL, Massa V, Mennitto A, Merler S, Merz V, Messina C, Messina M, Milano M, Minisini AM, Montesarchio V, Morabito A, Morgillo F, Mucci B, Nappi L, Napolitano F, Paciolla I, Pagliuca M, Palmieri G, Parola S, Pepe S, Petrillo A, Piantedosi F, Piccin L, Picozzi F, Pietroluongo E, Pignata S, Prati V, Riccio V, Rosanova M, Rossi A, Russo A, Salati M, Santabarbara G, Sbrana A, Simeone E, Silvestri A, Spada M, Tarantino P, Taveggia P, Tomei F, Vincenzo T, Trapani D, Trojanello C, Vanella V, Vari S, Ventriglia J, Vitale MG, Vitiello F, Vivaldi C, von Arx C, Zacchi F, Zampiva I, Zivi A, Daniele B, Ascierto PA; SCITO (Società Campana di ImmunoTerapia Oncologica). Ottaviano M, et al. Among authors: gridelli c. J Immunother Cancer. 2020 Oct;8(2):e001154. doi: 10.1136/jitc-2020-001154. J Immunother Cancer. 2020. PMID: 33060148 Free PMC article.
Lung cancer resection in octogenarian patients.
Spaggiari L, Petrella F, Maione P, Gridelli C. Spaggiari L, et al. Among authors: gridelli c. J Thorac Dis. 2018 Jun;10(Suppl 17):S1995-S1997. doi: 10.21037/jtd.2018.05.39. J Thorac Dis. 2018. PMID: 30023101 Free PMC article. No abstract available.
PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.
Paz-Ares LG, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C. Paz-Ares LG, et al. Among authors: gridelli c. J Clin Oncol. 2013 Aug 10;31(23):2895-902. doi: 10.1200/JCO.2012.47.1102. Epub 2013 Jul 8. J Clin Oncol. 2013. PMID: 23835707 Clinical Trial.
Lung cancer, elderly and immune checkpoint inhibitors.
Casaluce F, Sgambato A, Maione P, Spagnuolo A, Gridelli C. Casaluce F, et al. Among authors: gridelli c. J Thorac Dis. 2018 May;10(Suppl 13):S1474-S1481. doi: 10.21037/jtd.2018.05.90. J Thorac Dis. 2018. PMID: 29951299 Free PMC article. Review.
Combining immunotherapies to treat non-small cell lung cancer.
Spagnuolo A, Gridelli C. Spagnuolo A, et al. Among authors: gridelli c. Expert Rev Respir Med. 2019 Jul;13(7):621-634. doi: 10.1080/17476348.2019.1623027. Epub 2019 May 29. Expert Rev Respir Med. 2019. PMID: 31116072 Review.
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C. Paz-Ares L, et al. Among authors: gridelli c. Lancet Oncol. 2012 Mar;13(3):247-55. doi: 10.1016/S1470-2045(12)70063-3. Epub 2012 Feb 16. Lancet Oncol. 2012. PMID: 22341744 Clinical Trial.
New immunotherapy in the treatment of advanced renal cancer.
Muto A, Gridelli C. Muto A, et al. Among authors: gridelli c. Expert Opin Emerg Drugs. 2019 Dec;24(4):233-237. doi: 10.1080/14728214.2019.1696308. Epub 2019 Nov 28. Expert Opin Emerg Drugs. 2019. PMID: 31751164 Review.
437 results